Columbus McKinnon(US:CMCO)2026-02-09 22:05Financial Performance - Net sales for the three months ended December 31, 2025, were $258.655 million, an increase of 10.5% compared to $234.138 million for the same period in 2024[15] - Gross profit for the nine months ended December 31, 2025, was $256.539 million, up from $245.870 million in 2024, reflecting a growth of 4.4%[15] - Net income for the three months ended December 31, 2025, was $5.998 million, compared to $3.960 million in 2024, representing a year-over-year increase of 51.5%[16] - Basic income per share for the three months ended December 31, 2025, was $0.21, up from $0.14 in the same period last year, marking a 50% increase[15] - Comprehensive income for the nine months ended December 31, 2025, was $37.799 million, compared to a loss of $1.660 million in 2024, showing a significant turnaround[16] - Net income for the nine months ended December 31, 2025, was $8,695,000, compared to a net loss of $2,454,000 for the same period in 2024, representing a significant turnaround[22] Assets and Liabilities - Total assets as of December 31, 2025, were $1.762 billion, compared to $1.739 billion as of March 31, 2025, indicating a growth of 1.3%[13] - Total liabilities decreased to $839.669 million as of December 31, 2025, from $856.693 million as of March 31, 2025, a reduction of 2%[13] - The total shareholders' equity as of December 31, 2025, is $922,851,000, reflecting an increase from $882,095,000 as of March 31, 2025[18] - Cash and cash equivalents decreased to $35.484 million as of December 31, 2025, from $53.683 million as of March 31, 2025, a decline of 33.9%[13] Dividends and Shareholder Returns - The company declared dividends of $0.07 per common share for both the three months ended December 31, 2025, and 2024, maintaining consistency[15] - Dividends declared for the quarter ending September 30, 2025, amount to $2,011,000, slightly down from $2,015,000 in the previous quarter[18] Research and Development - Research and development expenses for the nine months ended December 31, 2025, were $14.044 million, down from $17.593 million in 2024, a decrease of 20.5%[15] Cash Flow and Investments - Cash provided by operating activities increased to $20,595,000 for the nine months ended December 31, 2025, up from $10,000,000 in the prior year[22] - The company reported a net cash used in investing activities of $(6,830,000) for the nine months ended December 31, 2025, compared to $(14,222,000) in the prior year[22] - The company completed the acquisition of Kito Crosby Limited for $2,700,000,000, which is expected to enhance its scale and geographic reach in the lifting solutions market[27] Customer and Revenue Insights - Total revenue from U.S. customers accounted for approximately 57% of total net sales during the three and nine months ended December 31, 2025[26] - Revenue recognized from customer advances for the nine months ended December 31, 2025, included $51,004,000, compared to $14,989,000 for the same period in 2024, indicating a significant increase[45] - The company’s total revenue for the nine months ended December 31, 2025, was $755,622,000, compared to $716,138,000 in 2024, indicating an overall increase of approximately 5.5%[47] Inventory and Performance Obligations - As of December 31, 2025, net inventories totaled $222,377,000, an increase from $198,598,000 as of March 31, 2025, reflecting a growth of approximately 11.9%[62] - The aggregate amount of unsatisfied performance obligations as of December 31, 2025, was approximately $37,538,000, with an expectation to recognize about 30% of this amount in the next twelve months[46] Tax and Compliance - The Company recorded an income tax expense of $1,781,000 for the three months ended December 31, 2025, compared to $1,929,000 for the same period in 2024, reflecting a decrease in tax expense[140] - The effective tax rate for the nine months ended December 31, 2025, is estimated to be approximately 15%, influenced by a favorable 16% impact from the New German Tax Law[142] Legal and Environmental Matters - The Company is engaged in litigation with Monsanto regarding indemnification claims, with ongoing legal defenses in place[131] - The District Court ruled that Travelers is obligated to defend the Company in its litigation against Monsanto, affirming coverage under existing insurance policies[133] Other Comprehensive Income - The ending balance of Accumulated Other Comprehensive Income (Loss) as of December 31, 2025, is $8,003,000, reflecting a change from a beginning balance of $(21,101,000) for the nine months ended[145] - For the three months ended December 31, 2025, the net current period other comprehensive income (loss) is $1,136,000, compared to a beginning balance of $6,867,000[145] Debt and Financing - The outstanding principal balance of Term Loan B was $426,316,000 as of December 31, 2025, with $11,244,000 in principal payments made during the nine months ended December 31, 2025[87] - The company plans to pay down approximately $50,000,000 in debt payments over the next 12 months, including principal payments on Term Loan B and payments on its AR Securitization Facility[87] Shareholder Equity and Stock Options - The company increased the number of authorized shares from 51,000,000 to 101,000,000, allowing for future equity issuances[110] - Stock options for 1,566,000 common shares were excluded from diluted EPS calculations for the three months ended December 31, 2025, due to being antidilutive[102]